相关实验视频

Updated: Jul 25, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.3K

通过分子对接,发现烯作为新型HCV NS5B聚合酶抑制剂

Tomasz M Karpiński1, Marcin Ożarowski2, Pedro J Silva3,4

  • 1Chair and Department of Medical Microbiology, Poznań University of Medical Sciences, Rokietnicka 10, 60-806 Poznań, Poland.

Pathogens (Basel, Switzerland)
|June 28, 2023
PubMed
概括

这项研究选了1893种烯对抗型肝炎病毒 (HCV) NS5B聚合酶的活性. 几种烯显示出有希望的in silico结果,其中mulberrofuran G,cochlearine A和 pawhuskin B被确定为潜在的竞争性抑制剂.

关键词:
肝炎肝炎是什么意思 肝炎肝炎是什么意思在的中.分子动力学分子动力学新的药物 新的药物植物化合物 植物化合物化物是一种化物.治疗治疗治疗治疗治疗治疗

更多相关视频

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.3K
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A1606:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.0K

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K